We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$62.3M
AUM Growth
+$11.3M
Cap. Flow
-$2.81M
Cap. Flow %
-4.51%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
3
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
WHWK
Whitehawk Therapeutics
WHWK
+$2.64M
2
VRNA
Verona Pharma
VRNA
+$175K
3
AMWL icon
American Well
AMWL
+$8

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
1
Annexon
ANNX
$834M
$43.8M 70.35%
7,406,024
– –
AKBA icon
2
Akebia Therapeutics
AKBA
$354M
$7.59M 12.17%
5,747,906
– –
VRNA
3
DELISTED
Verona Pharma
VRNA
$5.92M 9.5%
205,880
-7,120
-3% -$175K
AMWL icon
4
American Well
AMWL
$180M
$4.97M 7.97%
523,785
-1
-0% -$8
WHWK
5
Whitehawk Therapeutics
WHWK
$190M
$1.36K ﹤0.01%
659
-1,630,171
-100% -$2.64M

Similar funds

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
AFA
Atlas Financial Advisors Oroville, California $64.1M AUM 8.36% 1-Year Est. Return
MCC
Maiden Cove Capital Cape Elizabeth, Maine $65.4M AUM
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
MC
Meketa Capital Westwood, Massachusetts $44.6M AUM
OAM
Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return
IP
Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return
JCP
Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Alerce Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, Alerce Investment Management held 5 positions worth $62.3M, up 22% from $51M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Alerce Investment Management withdrew a net $2.81M in Q3 2024, reducing 3 holdings. Its largest reduction was Whitehawk Therapeutics, cutting an estimated $2.64M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Alerce Investment Management's biggest Q3 2024 reduction was Whitehawk Therapeutics, cutting an estimated $2.64M.
  • Alerce Investment Management's ten largest holdings make up 100% of its $62.3M portfolio in Q3 2024.
  • Alerce Investment Management opened 0 new positions and closed 0 in Q3 2024.
  • Alerce Investment Management's portfolio value rose 22% quarter-over-quarter to $62.3M.

Based on Alerce Investment Management's 13F filing for Q3 2024, filed 13 Nov 2024.